Avacta Shares More Than Double in a Few Days, But Virus Kit May Whack Up an Even Better Performance than that.
From the FCA's spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2018 and thus far in 2019 (by net short position %, those in bold not on the list at the start of 2019) – and if this position has increased (red), reduced (green) or remained unchanged (black) since last week...
Something a little different this morning and that is another quick look at the AIM market-listed Abcam (ABC), which I last wrote about back in March. Back then I concluded about the "pretty fascinating company making, sourcing and selling a range of 'highly validated biological binders and assays to help study the important targets in critical biological pathways'" that:
I have not written on Abcam (ABC) but given the nature of its last appearance on this website ("Abcam fat cats and useless 1%-er Non Execs") many will think just desserts about today's 11% share price fall (as I write)…
Roger Lawson of ShareSoc is er…not always right but his latest battle is one where he is bang on the money. Lawson is a shareholder in Abcam (ABC) and thinks the board is taking the piss and need an AGM wake-up call. He is absolutely right.
What can be seen on the daily chart of Abcam is the way that since the sharp spike through the 200 day line then lying towards 400p, and now at 553p.
Search ShareProphets |
Recent Comments |